PubMed · 1966 · 23 citations · 0 references
Life SciencesBiochemistryPharmacologyDrug MetabolismEnzymologyMetabolismCellular RespirationEnzyme KineticsMetabolism Of Anticancer AgentsMetabolite KineticsAlkylation ProcessesAlkylation ReactionsCarbon DioxideChemical Metabolism KineticsDegradationKinetic Data AnalysisN-oxidation Of Nitrogen-containing CompoundsNitrogen Mustards
Summary In vitro kinetic studies in various biologic media have led to the observation of an enzyme in blood serum that catalyzes the reaction between secondary nitrogen mustards and carbon dioxide to form substituted oxazolidinones. This reaction causes the very rapid degradation of certain nitrogen mustards frequently employed in cancer chemotherapy. Upon contact with blood or animal tissues, agents such as degranol and nor-HN2 are immediately transformed into products incapable of undergoing typical alkylation reactions. In light of these observations reevaluation of pharmacologic data thus far collected on these nitrogen mustards is indicated. Interpretation of the kinetic data obtained indicates that the enzyme catalyzes carbamate formation—a reaction of importance for the transport of carbon dioxide in blood. R2NH + CO2 ⇌ R2NCOO⊖ + H⊕ It is proposed that a normal metabolic function of this enzyme is to catalyze this reaction during respiration.